February 20, 2014
Mitsubishi Tanabe Pharma Corporation (MTPC) and Daiichi Sankyo are aiming to increase sales of their struggling diabetes drug Tenelia (teneligliptin), a dipeptidyl peptidase-4 (DPP-4) inhibitor that they comarket, by shoring up their sales activities. Sales of Tenelia, launched in September...read more